Care of the oncology patient in the picu

Robert Greiner, Stacey Peterson-Carmichael, Jennifer A. Rothman, Kenneth W. Gow, Robert Tamburro, Raymond Barfield

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There are numerous malignant conditions that place the pediatric patient at great risk requiring the need of critical care services. Therefore, it is essential that the pediatric critical care provider possess a sound understanding of these conditions such that they may be anticipated, recognized and treated effectively. Of these conditions, perhaps none requires the prompt, well conceived care of a pediatric intensivist as much as a malignant mediastinal mass. A definitive diagnosis must be established balancing the likelihood of a definitive result with the risk of the diagnostic procedure and the associated sedation. A clear understanding of the findings that suggest a patient is at high risk for airway compromise is essential. Hyperleukocytosis is another malignant condition associated with significant morbidity and mortality as a result of leukostasis. Leukostasis is a clinical condition characterized by progressive and potentially severe neurologic or respiratory disease attributable to small vessel infiltration and occlusion by leukemic blasts. Hypercalcemia is another disorder that may be associated with a variety of malignant processes. Although relatively rare in children, it may result in a number of life-threatening conditions including cardiac dysrhythmias, neurologic impairment, and renal failure. Additionally, it is well-established that varying degrees of coagulopathy are present in most patients with advanced malignancy. Perhaps most notable, acute promyelocytic leukemia is associated with such a high incidence of death near the time of presentation secondary to intracranial and pulmonary hemorrhages that it is viewed as a medical emergency. Other forms of leukemia may be associated with other pathophysiological consequences that may also be life-threatening. For example, lactic acidosis resulting from a high rate of glycolysis is a very rare, but life-threatening complication of hematologic malignancies. A heightened sense of alertness for these rare conditions may result in earlier detection, more effective therapy, and better outcomes for these children.

Original languageEnglish (US)
Title of host publicationPediatric Critical Care Medicine
Subtitle of host publicationVolume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems
PublisherSpringer-Verlag London Ltd
Pages343-361
Number of pages19
ISBN (Electronic)9781447164166
ISBN (Print)9781447164159
DOIs
StatePublished - Jan 1 2014

Fingerprint

Leukostasis
Patient Care
Critical Care
Pediatrics
Nervous System
Leukemic Infiltration
Lactic Acidosis
Acute Promyelocytic Leukemia
Intracranial Hemorrhages
Hypercalcemia
Glycolysis
Hematologic Neoplasms
Renal Insufficiency
Cardiac Arrhythmias
Leukemia
Emergencies
Morbidity
Lung
Mortality
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Greiner, R., Peterson-Carmichael, S., Rothman, J. A., Gow, K. W., Tamburro, R., & Barfield, R. (2014). Care of the oncology patient in the picu. In Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems (pp. 343-361). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-6416-6_24
Greiner, Robert ; Peterson-Carmichael, Stacey ; Rothman, Jennifer A. ; Gow, Kenneth W. ; Tamburro, Robert ; Barfield, Raymond. / Care of the oncology patient in the picu. Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems. Springer-Verlag London Ltd, 2014. pp. 343-361
@inbook{45a91e2598944022a35ebae5caec085a,
title = "Care of the oncology patient in the picu",
abstract = "There are numerous malignant conditions that place the pediatric patient at great risk requiring the need of critical care services. Therefore, it is essential that the pediatric critical care provider possess a sound understanding of these conditions such that they may be anticipated, recognized and treated effectively. Of these conditions, perhaps none requires the prompt, well conceived care of a pediatric intensivist as much as a malignant mediastinal mass. A definitive diagnosis must be established balancing the likelihood of a definitive result with the risk of the diagnostic procedure and the associated sedation. A clear understanding of the findings that suggest a patient is at high risk for airway compromise is essential. Hyperleukocytosis is another malignant condition associated with significant morbidity and mortality as a result of leukostasis. Leukostasis is a clinical condition characterized by progressive and potentially severe neurologic or respiratory disease attributable to small vessel infiltration and occlusion by leukemic blasts. Hypercalcemia is another disorder that may be associated with a variety of malignant processes. Although relatively rare in children, it may result in a number of life-threatening conditions including cardiac dysrhythmias, neurologic impairment, and renal failure. Additionally, it is well-established that varying degrees of coagulopathy are present in most patients with advanced malignancy. Perhaps most notable, acute promyelocytic leukemia is associated with such a high incidence of death near the time of presentation secondary to intracranial and pulmonary hemorrhages that it is viewed as a medical emergency. Other forms of leukemia may be associated with other pathophysiological consequences that may also be life-threatening. For example, lactic acidosis resulting from a high rate of glycolysis is a very rare, but life-threatening complication of hematologic malignancies. A heightened sense of alertness for these rare conditions may result in earlier detection, more effective therapy, and better outcomes for these children.",
author = "Robert Greiner and Stacey Peterson-Carmichael and Rothman, {Jennifer A.} and Gow, {Kenneth W.} and Robert Tamburro and Raymond Barfield",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-6416-6_24",
language = "English (US)",
isbn = "9781447164159",
pages = "343--361",
booktitle = "Pediatric Critical Care Medicine",
publisher = "Springer-Verlag London Ltd",

}

Greiner, R, Peterson-Carmichael, S, Rothman, JA, Gow, KW, Tamburro, R & Barfield, R 2014, Care of the oncology patient in the picu. in Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems. Springer-Verlag London Ltd, pp. 343-361. https://doi.org/10.1007/978-1-4471-6416-6_24

Care of the oncology patient in the picu. / Greiner, Robert; Peterson-Carmichael, Stacey; Rothman, Jennifer A.; Gow, Kenneth W.; Tamburro, Robert; Barfield, Raymond.

Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems. Springer-Verlag London Ltd, 2014. p. 343-361.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Care of the oncology patient in the picu

AU - Greiner, Robert

AU - Peterson-Carmichael, Stacey

AU - Rothman, Jennifer A.

AU - Gow, Kenneth W.

AU - Tamburro, Robert

AU - Barfield, Raymond

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There are numerous malignant conditions that place the pediatric patient at great risk requiring the need of critical care services. Therefore, it is essential that the pediatric critical care provider possess a sound understanding of these conditions such that they may be anticipated, recognized and treated effectively. Of these conditions, perhaps none requires the prompt, well conceived care of a pediatric intensivist as much as a malignant mediastinal mass. A definitive diagnosis must be established balancing the likelihood of a definitive result with the risk of the diagnostic procedure and the associated sedation. A clear understanding of the findings that suggest a patient is at high risk for airway compromise is essential. Hyperleukocytosis is another malignant condition associated with significant morbidity and mortality as a result of leukostasis. Leukostasis is a clinical condition characterized by progressive and potentially severe neurologic or respiratory disease attributable to small vessel infiltration and occlusion by leukemic blasts. Hypercalcemia is another disorder that may be associated with a variety of malignant processes. Although relatively rare in children, it may result in a number of life-threatening conditions including cardiac dysrhythmias, neurologic impairment, and renal failure. Additionally, it is well-established that varying degrees of coagulopathy are present in most patients with advanced malignancy. Perhaps most notable, acute promyelocytic leukemia is associated with such a high incidence of death near the time of presentation secondary to intracranial and pulmonary hemorrhages that it is viewed as a medical emergency. Other forms of leukemia may be associated with other pathophysiological consequences that may also be life-threatening. For example, lactic acidosis resulting from a high rate of glycolysis is a very rare, but life-threatening complication of hematologic malignancies. A heightened sense of alertness for these rare conditions may result in earlier detection, more effective therapy, and better outcomes for these children.

AB - There are numerous malignant conditions that place the pediatric patient at great risk requiring the need of critical care services. Therefore, it is essential that the pediatric critical care provider possess a sound understanding of these conditions such that they may be anticipated, recognized and treated effectively. Of these conditions, perhaps none requires the prompt, well conceived care of a pediatric intensivist as much as a malignant mediastinal mass. A definitive diagnosis must be established balancing the likelihood of a definitive result with the risk of the diagnostic procedure and the associated sedation. A clear understanding of the findings that suggest a patient is at high risk for airway compromise is essential. Hyperleukocytosis is another malignant condition associated with significant morbidity and mortality as a result of leukostasis. Leukostasis is a clinical condition characterized by progressive and potentially severe neurologic or respiratory disease attributable to small vessel infiltration and occlusion by leukemic blasts. Hypercalcemia is another disorder that may be associated with a variety of malignant processes. Although relatively rare in children, it may result in a number of life-threatening conditions including cardiac dysrhythmias, neurologic impairment, and renal failure. Additionally, it is well-established that varying degrees of coagulopathy are present in most patients with advanced malignancy. Perhaps most notable, acute promyelocytic leukemia is associated with such a high incidence of death near the time of presentation secondary to intracranial and pulmonary hemorrhages that it is viewed as a medical emergency. Other forms of leukemia may be associated with other pathophysiological consequences that may also be life-threatening. For example, lactic acidosis resulting from a high rate of glycolysis is a very rare, but life-threatening complication of hematologic malignancies. A heightened sense of alertness for these rare conditions may result in earlier detection, more effective therapy, and better outcomes for these children.

UR - http://www.scopus.com/inward/record.url?scp=84948954720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948954720&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-6416-6_24

DO - 10.1007/978-1-4471-6416-6_24

M3 - Chapter

SN - 9781447164159

SP - 343

EP - 361

BT - Pediatric Critical Care Medicine

PB - Springer-Verlag London Ltd

ER -

Greiner R, Peterson-Carmichael S, Rothman JA, Gow KW, Tamburro R, Barfield R. Care of the oncology patient in the picu. In Pediatric Critical Care Medicine: Volume 3: Gastroenterological, Endocrine, Renal, Hematologic, Oncologic and Immune Systems. Springer-Verlag London Ltd. 2014. p. 343-361 https://doi.org/10.1007/978-1-4471-6416-6_24